Abstract
The mir-THYpe® exam is a molecular classifier for indeterminate cytology thyroid nodules, developed by the startup Onkos in partnership with the Cancer Hospital of Barretos. It uses advanced molecular biology techniques (microRNA profiling and mutation analysis) and Artificial Intelligence, showing itself capable of reducing potentially unnecessary thyroid surgeries by up to 74.6%. It has…